English
English
Hebrew
Alpha Tau

Treating Cancer With Precision

  • Home

  • Alpha DaRT

  • Treatment

  • Clinical Trials

    • All Clinical Trials
    • Skin Cancer
    • Oral Cavity Cancer
    • Self-Assessment Form
    • Preclinical Trials
  • Publications

    • Clinical Publications
    • Pre-Clinical Pubications
    • Scientific Posters
  • About

    • About Alpha Tau
    • News & Blog
    • Careers
    • Management
    • Scientific Advisory Board
    • Board of Directors
    • Contact
  • Investors

    • Stock Information
    • SEC Filings
    • Events & Presentation
    • Corporate Governance
  • More

    Use tab to navigate through the menu items.
    nicholas-cappello-Wb63zqJ5gnE-unsplash (1)_edited.jpg

    Investors | Stock Information | SEC Filings | Events & Presentation | News & PR | Corporate Governance

    Categories
    • Press Releases
    • All News
    • In the Media
    • Blog
    Sign up
    Archive
    • March 2022
    • January 2022
    • November 2021
    • October 2021
    • July 2021
    • June 2021
    • December 2020
    • June 2020
    • April 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • June 2019
    • April 2019
    • March 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • May 2018
    • April 2018
    • March 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • July 2017
    • May 2017
    • April 2017
    • February 2017
    • January 2017
    Follow Us
    • Grey Facebook Icon
    • Grey LinkedIn Icon
    • Grey Twitter Icon
    • YouTube
    New Alpha DaRT Research Collaboration on Immune Stimulation in the Treatment of Breast Cancer
    Alpha Tau Medical

    New Alpha DaRT Research Collaboration on Immune Stimulation in the Treatment of Breast Cancer

    JERUSALEM, Jan 20, 2022 – Alpha Tau Medical Ltd. (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha...
    Results of First US Clinical Trial of Alpha DaRT™
    Alpha Tau Medical

    Results of First US Clinical Trial of Alpha DaRT™

    Alpha Tau Announces Results of First US Clinical Trial of Alpha DaRT™ in Malignant Skin & Soft Tissue Cancers, Showing Complete Response...
    Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer
    Alpha Tau Medical

    Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer

    JERUSALEM, Dec. 31, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...
    Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)
    Alpha Tau Medical

    Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)

    JERUSALEM, Nov. 3, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...
    Completion of Enrollment in 1st US Clinical Trial & Achievement of 1st Primary Objective
    Alpha Tau Medical

    Completion of Enrollment in 1st US Clinical Trial & Achievement of 1st Primary Objective

    JERUSALEM, Oct. 25, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...
    Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM
    Alpha Tau Medical

    Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM

    JERUSALEM, Oct. 8, 2021 -- Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, is pleased to...
    1
    2345
    Alpha Tau
    • Home

    • Alpha DaRT

    • Treatment

    • Clinical Trials

      • All Clinical Trials
      • Skin Cancer
      • Oral Cavity Cancer
      • Self-Assessment Form
      • Preclinical Trials
    • Publications

      • Clinical Publications
      • Pre-Clinical Pubications
      • Scientific Posters
    • About

      • About Alpha Tau
      • News & Blog
      • Careers
      • Management
      • Scientific Advisory Board
      • Board of Directors
      • Contact
    • Investors

      • Stock Information
      • SEC Filings
      • Events & Presentation
      • Corporate Governance
    • More

      Use tab to navigate through the menu items.

      Looking for clinical trials?

      See if you're eligible
      Newsletter
      • LinkedIn
      • YouTube
      • Twitter
      • Facebook

      Privacy Policy

      Contact us